Breaking Through The Future WeMed Medical Won The Technology Innovation Award
The theme of the 13th CFS2024 and Amazing 2024 Innovation Entrepreneur Festival is "Finding New Driving Forces for China's Economy". As the most influential thought event in China's economic field, the 13th CFS brought together visionary business leaders, economists, entrepreneurs and young people from home and abroad to share opportunities and promote recovery and growth in China.
As an innovator in the field of medical, WeMed Medical has always been at the forefront of innovation, based on clinical guidance, taking patient needs as the starting point, and technological innovation as the driving force, constantly promoting the innovation of medical services. The company's R&D team is composed of top talents from multiple disciplines. They use cross-border thinking and cutting-edge technology to continuously explore new areas of medical technology.
Beijing WeMed Medical Technology Co., Ltd. is a nationally accredited "Little Giant" enterprise specializing in the provision of interventional and orthopedic diagnosis and treatment equipment with comprehensive solutions. We offer a wide range of interventional product lines including Medical Angiography X-ray System, Mobile C-arm X-ray System, and Endovascular Robotic System.
We are committed to innovation-driven development with an average product innovation iteration completed every two years. The company has emerged as one of the exclusive five global entities engaged in the production and research of vascular interventional surgical robots. And holds the second-highest number of first invention patents in this field globally.
Following an overseas development strategy encompassing both "bringing in" and "going out," we successfully acquired Italy's EUROCOLUMBUS company through overseas mergers and acquisitions. This move allowed us to establish a global dual center for realizing international strategic layouts across product research and development, manufacturing, sales and marketing.
WeMed Medical is well aware that as a medical technology company, its social responsibility is not only to pursue economic benefits, but also to bring more health and well-being to society through technological innovation. The company has demonstrated a strong sense of social responsibility and positive action in medical poverty alleviation, health education, and response to public health events, and strives to improve the accessibility and inclusiveness of medical services.
Looking to the future, WeMed Medical will continue to focus on innovation, increase R&D investment, and make more breakthroughs in the fields of medical imaging. At the same time, it will actively respond to the national "Healthy China" strategy and contribute to the realization of universal health through scientific and technological innovation.
